LIN

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

✓

Return

+0.42%

Status

scored

Maintain LIN at current weight with no adds or trims; stop placed at $475.00 (close) calibrated between noise protection and whipsaw avoidance, with explicit upgrade trigger at close >$488.78 on above-average volume and downgrade trigger at close <$470.59 with red MACD histogram tightening stop to $465. The Hold thesis rests on full valuation (31x trailing P/E) offsetting structural quality (80% contracted revenue, 31-year dividend streak, oligopoly), awaiting Q3 2026 earnings as the binary reassessment catalyst in 4-6 weeks.

Outcome

✓

Return

-0.47%

Status

scored

Trim 30-40% of LIN at the 200 SMA resistance zone ($484-$485) to lock in alpha ahead of the Q3 2026 binary catalyst, moving to 50-70% of benchmark weight; reanchor the protective stop on the residual 60-70% to $465 (below the 50 SMA), reclassifying $510 as a re-engagement trigger rather than a stop. The 200 SMA at $484.50 has now been rejected twice, and three prior Underweight precedents validate trim execution at this exact technical signature, producing +1.0% to +1.4% alpha. Re-engagement is warranted only on confirmed breakout above $510 on volume ≥2.5M shares with MACD confirmation, or on a flush to the $440-460 zone where forward 5-year IRR becomes materially more attractive.

Outcome

✗

Return

-1.22%

Status

scored

Maintain LIN at $489.95 as technical recovery (MACD crossover, price above all three major MAs) has invalidated the prior Underweight execution thesis, but Q3 2026 earnings in 3-4 weeks remains an unresolved binary catalyst that prevents adding at 31.6x trailing P/E with structural macro headwinds; trim 20-25% into the $510-520 resistance cluster, hard stop at $474, and upgrade to Overweight on beat-and-raise or downgrade to Underweight on miss.

Outcome

✗

Return

+1.57%

Status

scored

Trim 30-40% of LIN via limit orders into the $485-490 resistance zone while maintaining a 60-70% residual position with a hard stop at $465; re-engage on a confirmed close above $495 on volume ≥1.5x the 60-day average or a pullback to the $440-460 zone. The Underweight rating reflects premium valuation at 24.7x forward P/E with a 10-15% multiple premium to peers, a confirmed death cross, and MACD still negative at -0.82 into a Q3 binary catalyst 3-4 weeks away.

Outcome

✓

Return

+0.60%

Status

scored

The rating is HOLD with a $487 price target and 4-6 week time horizon through Q3 2026 earnings in late October. The position should be maintained without adding or trimming at current levels ($479.48), with a put spread hedge (long $465 put, short $445 put, 3-4 week expiry) sized to fully neutralize beta-plus-duration exposure, and tiered add triggers at $483.50 and $455-465 levels pending technical confirmation.

Outcome

✗

Return

+2.14%

Status

scored

Trim 30% of the LIN position via limit orders into the $475-480 triple-resistance zone over the next 3-5 sessions, with a hard stop on the remaining 70% at $458; execute the trim at market if the zone is not tested within 5 sessions. The bearish case rests on Q2 2026 gross margin contraction (47.7% vs 49.3% prior year), capital returns at 145% of FCF funded by $6.3B incremental net debt, and technically bearish structure with price below all three major moving averages and a confirmed death cross. Q3 2026 earnings in late October serves as the binary reassessment catalyst with three resolution paths: thesis confirmation on revenue reacceleration ≥+8% YoY plus gross margin recovery to ≥48%, thesis broken on EPS miss below $3.95 with soft guidance, or preserve Underweight on ambiguous in-line print pending a 50/200 SMA reclaim trigger.

Outcome

✗

Return

-1.10%

Status

scored

Portfolio Manager maintains LIN at HOLD rating with $487 price target, directing investors to maintain current exposure without adding at $474.65 or trimming in the chop zone. The decision is driven by confirmed death cross, bearish volume divergence, and a Q3 binary catalyst 4-5 weeks away, while the fundamental franchise floor remains intact (80% contracted revenue, 31-year dividend growth streak, oligopoly structure). Key invalidation triggers are set at weekly close below $445 on rising volume (trim 25-33%) or volume spike >1.5x average with close below $440 (immediate trim to 75%).

Outcome

✓

Return

+0.27%

Status

scored

Hold LIN at current $473.37 weight with no additions or trims ahead of the late-October Q3 2026 earnings catalyst. Death cross confirmed (50 SMA $481.45 below 200 SMA $482.49) and price below both moving averages, paired with a short-duration Treasury hedge (SHY) to neutralize 30x trailing P/E duration risk in the 5%-pinned rate regime. Upgrade triggers on close above $482.49 with volume ≥2.5M; downgrades on weekly close below $445 on rising volume.

Outcome

✓

Return

+0.28%

Status

scored

Maintain LIN at current weight without trimming or adding; the Hold rating captures the high-quality franchise metrics (28% operating margins, 18.4% ROE, 80% contracted revenue, 31-year dividend streak) while the Q3 earnings catalyst in late October resolves the current technical ambiguity with three defined resolution paths.

Outcome

✗

Return

+0.46%

Status

scored

Trim 40% of LIN via tiered execution at the $478-483 death cross resistance zone, with Tier 1 (20%) at $478-480 on first test and Tier 2 (20%) at $481-483 contingent on acceptance above $480 and Tier 1 fill, retaining 60% core for moat insurance; if the zone is not tested within 5 sessions, execute trim at market. The rating reflects convergence of all three risk analysts on directional trim, justified by the asymmetric risk/reward at resistance versus franchise-floor levels, with a $487 stop (1.5 ATR above upper trim zone) and hard structural invalidation on weekly close below $445; re-evaluate at Q3 2026 earnings in late October.

Outcome

✓

Return

+0.37%

Status

scored

Maintain LIN at current weight with a Hold rating as four of four analysts converge on Hold, lesson history (9/23 Overweight producing -0.3% alpha) decisively disqualifies tactical starters at $468, and Q3 2026 earnings in late October represents a binary fundamental catalyst 4-5 weeks away that should not be front-run given deteriorating trade math (0.9:1 R:R), structural gross margin compression (160 bps over 5 consecutive quarters), and 47% sequential FCF decline threatening the buyback program.

Outcome

–

Return

-0.34%

Status

scored

Overweight rating reflects a structural upgrade from Hold, justified by forward P/E compression from ~29.5x to ~24x, MACD histogram compression from -3.83 to -0.07, and RSI reset from 29 to 45. Execute Tranche 1 (25% of intended position) at $469.72 with stop at $457.50, preserving 75% dry powder for three confirmation tranches (MACD line cross, 200 SMA reclaim at $480.53, 50 SMA flip at $485.97).

Outcome

✗

Return

+1.03%

Status

scored

Maintain LIN at Hold rating as the 9/21/2026 reflection is dispositive against bearish proposals—the most recent validated decision confirmed that selling a structurally intact compounder at downtrend levels was unwarranted. The franchise floor (80% contracted take-or-pay revenue, A-rated credit, 31-year dividend growth streak) remains intact with current price $6-8 above the $458.50 entry, while the aggressive analyst's bear case predicting $449-$400 test has not materialized across four decision windows. Hold with active relative-underperformance framing, tightened invalidation triggers (weekly close below $445), and Q3 2026 earnings late October as next binary catalyst.

Outcome

✗

Return

+1.62%

Status

scored

Maintain existing LIN exposure at current weight while explicitly framing Hold as an active relative underperformance stance; pair with short-duration Treasury hedge to neutralize duration risk on a 29.5× P/E in a 5% yield regime; do not initiate new longs at $458.50 as the trader's Buy proposal reproduces the alpha-leak pattern that twelve consecutive LIN decisions have explicitly disqualified; reassess at Q3 2026 earnings late October.

Outcome

✓

Return

-0.63%

Status

scored

Maintain LIN at current weight without adding at $460.40 or distributing below current levels; Hold is the intellectually honest position because the bear wins the timing debate (all three MAs broken, MACD expanding negative, RSI 32.9, 0.5% revenue CAGR) while the bull wins the quality debate (28% operating margins, 18.4% ROE, $5B FCF, 80% recurring revenue, oligopoly structure, $5B buyback floor). The regime gate disqualifies starters and prior 8+ decision lesson history shows tactical overlays on either side leak alpha in this signature.

Outcome

✓

Return

+0.42%

Status

scored

Maintain LIN at current weight given symmetric risk/reward at $458, with downside to $420-440 and upside to ~$510 (~11%); the franchise floor (80% contracted take-or-pay revenue, 0.727 beta, 31-year dividend streak) prevents trimming, while compressed FCF (-50% to ~$833M TTM), broken 200 SMA, and declining 50 SMA disqualify fresh entries. Use the Neutral analyst's binary triggers: add 1% on close >$476.48 with positive MACD histogram; trim 25-33% on close <$454.30 on volume, with hard stop at $446 on any fresh entries.

Outcome

✓

Return

-0.78%

Status

scored

The Research Manager, Trader, and all three risk analysts unanimously converge on Hold, and the 7+ decision lesson history is dispositive: tactical overlays on both sides of this signature have produced essentially zero cumulative alpha, while disciplined Holds have recently captured +0.1% to +0.3% alpha per decision as the franchise floor caps downside.

Outcome

✓

Return

-0.19%

Status

scored

Analysts recommend holding LIN shares without adding or trimming, as six consecutive decisions have produced essentially zero cumulative alpha. The current setup shows fundamental headwinds (four consecutive quarters of gross margin compression at 49.3% to 47.7%, FCF cut ~50% from $1.67B to $833M, net debt up $2B) alongside technical weakness (price below 50 and 200 SMAs, MACD at -7.46, RSI at 33), but the defensive franchise floor (80% contracted revenue, 0.727 beta, A-rated credit, 31-year dividend growth streak, $4.16B TTM FCF) caps downside. Predefined re-entry triggers set at close >$478.20 with MACD/RSI confirmation, with $385 as invalidation level.

Outcome

✓

Return

-0.31%

Status

scored

Maintain neutral-weight exposure on LIN as the six-decision history demonstrates that tactical overlays on either side produce essentially zero cumulative alpha against this quality compounder. The 200 SMA break at $464.41 represents a 3% violation on closing basis, but the franchise floor (take-or-pay backlog, 1.67x net debt/EBITDA, 0.727 beta) contains downside risk. The regime gate disqualifies both the Aggressive analyst's BUY/starter and the Conservative analyst's UW/Sell, as all four regime-gate conditions are met (FCF compression, leverage increase, premium PE in hawkish regime, 200 SMA break with expanding negative MACD).

Outcome

✓

Return

-0.39%

Status

scored

Maintain Hold rating on LIN as the compounder thesis remains structurally intact despite macro-driven price weakness—the 80% contracted take-or-pay revenue, A-rated credit, and 1.67x net debt/EBITDA provide a documented franchise floor that capped downside and continues to do so. Do not initiate new positions at ~$466 as the 9/9 regime gate explicitly disqualifies mean-reversion overlays when structural deterioration coincides with technical breakdown; wait for confirmation (10 EMA reclaim $473.61 with expanding volume and MACD flattening) before scaling in existing exposure. Next reassessment point is Q3 2026 earnings in late October as the binary fundamental catalyst.

Outcome

–

Return

+1.00%

Status

scored

Trim LIN to 50-70% of benchmark weight using a three-tranche approach: initiate 1/3 of the trim at current levels ($461-465), add 1/3 on any relief bounce into $475-485, and reserve 1/3 for a confirmed breakdown below $460 on >3M volume or a fundamental catalyst. Use $488-492 stops (two ATR) and pre-commit re-entry only on weekly close above $478 with MACD turning positive and dovish macro shift; reassess at Q3 2026 earnings in late October.

Outcome

✗

Return

-1.08%

Status

scored

Maintain core LIN exposure with a 0.25% starter position at $466-472 and hard stop at $463.37, calibrating position size smaller than the breakdown pattern would suggest per the 9/8 LIN UW reflection lesson. Scale to 0.75% of portfolio if price closes above $477.87 on >2.5M volume with RSI reclaiming 40 and MACD cross; trim half and re-evaluate at $450 if price closes below $463.37 on volume. The decision acknowledges documented alpha leakage from three prior passive Hold calls (9/2: -2.1%, 9/3: -0.6%, 9/4: -1.4%) while recognizing the structural headwinds (FCF compression, leverage, premium 30x P/E, hawkish regime) that argue against upgrading to Overweight.

Outcome

–

Return

-0.37%

Status

scored

Analysts unanimously recommend trimming 33–40% of LIN holdings via a staged two-tranche approach—25% front-loaded immediately and 10–15% reserved for any relief bounce into $475–$485—while anchoring the remaining ~60% core position to a structure-based stop at $466. The technical breakdown is confirmed (close below the lower Bollinger Band on +30% volume, RSI 33, failed MACD divergence, lower-low sequence), but fundamentals remain intact (80% contracted revenue, 1.67x leverage, A-rated credit), warranting a partial exit rather than a full Sell.

Outcome

✗

Return

-1.92%

Status

scored

Maintain LIN at Hold with an active two-sided execution framework rather than passive inaction; scale in 33-50% of intended new exposure on confirmed technical repair (10 EMA reclaim at $483, RSI >45, above-average volume), and pre-commit a 25-33% trim if price exceeds $495 with declining volume into broken 50 SMA resistance. Hard exit triggered on close below $465.

Outcome

✗

Return

-0.96%

Status

scored

Maintain LIN at benchmark weight (Hold) with three explicit active elements: execute protective collar ($510 calls / $470 puts, ~60 days, 1.5% notional premium ceiling), set a 4-week reassessment clock, and harvest 10-15% on relief rallies into $495-500. Reject aggressive BUY per 8/28 OW lesson (tier increase without binary catalyst = Hold in disguise). Stop at $478 (200 SMA); hard stop $465.

Outcome

✗

Return

-1.08%

Status

scored

Maintain LIN at current position size within the trader's defined risk framework, neither tiering up to Overweight despite constructive basing dynamics nor trimming further due to documented evidence that moves without binary catalysts produce "Hold in disguise" and defensives without fresh catalysts generate minimal alpha. Hold stop at $473; await either breakout above $503.50 with volume >1.7M or flush to $475-480 with volume >2M and RSI <35 to upgrade, with Q3 earnings in late October as the next binary fundamental catalyst over the 4-8 week time horizon.

Outcome

–

Return

+0.14%

Status

scored

Underweight rating on LIN with a 15-20% position trim recommended at current levels ($480-490), executed in 2-3 tranches over 1-2 weeks using relief rallies to $495-500 as exit opportunities; hard stop on remaining position at $474 daily close basis. Re-entry triggers include adding back 50% of trim on confirmed close >$504 with volume >2.5M plus MACD and RSI confirmation, or pullback to $440-455 zone with bullish reversal candle. Key risks include gross margin compression (47.7% in 2Q26 vs 49.3%), trailing P/E of 31.36x for ~1% revenue CAGR business, and negative MACD with RSI sub-50.

Outcome

–

Return

-0.58%

Status

scored

Reduce LIN exposure by trimming 15-20% over 2-4 weeks, using relief rallies toward $500-504 as exit opportunities, or trim 8-10% on confirmed failed retest of $495-496 or close below $478 with volume. Execute protective collar ($520 calls / $465 puts, ~60 days) and tighten hard stop to $465 closing basis, with re-entry triggers set for close above $510 with volume confirmation or pullback to $460-475 with bullish reversal.

Outcome

✓

Return

+0.01%

Status

scored

LIN is upgraded from Hold to Overweight based on Q2 2026 fundamental acceleration (revenue +9.3%, EPS +11.3% with margin expansion) and technical basing signals (MACD histogram positive, ATR compression from 12.82 to 8.88, 200 SMA defended at $477). Position will be built to 4–4.5% portfolio via three staged entries: 1% at market ($487–490), 1.5% on confirmed $505 breakout, and 1.5–2% on $477 retest, with a protective collar ($515 calls / $472 puts) executed immediately and hard stop at $465.

Outcome

✓

Return

+0.86%

Status

scored

The unanimous Hold rating reflects a balanced setup where LIN's fortress fundamentals (record $8.1B backlog, 31-year dividend growth, A-rated credit) justify retention, but 24.8x forward P/E with 2.08 PEG and 27 sessions capped below $495.61 preclude aggression. Three execution refinements are recommended: trim 10-15% into $500-505 resistance, replace the $415-430 add zone with a $474-477 bullish confirmation retest, and pre-commit to no adds before Jackson Hole with ≤50% sizing through the catalyst window.

Outcome

–

Return

-1.02%

Status

scored

Trim LIN to 50–75% underweight relative to benchmark, rejecting shorting due to the $4.5B annual buyback program protecting tight stops. Hard stop on remaining long at $465 (2.5 ATR below current), with three re-entry triggers: 50 SMA reclaim at $507–510 with volume >3M plus MACD >0 and RSI >50; pullback to $460–475 for better entry multiple; or peer-group multiple compression of 10–15%. The asymmetric thesis favors bears requiring only one of five independent paths (200 SMA break, MACD persistence negative, Q3 non-confirmation, multiple compression, hydrogen policy setback) versus bulls needing all four forward assumptions to confirm simultaneously.

Outcome

✓

Return

+0.64%

Status

scored

Maintain LIN at current position size with three key execution refinements: transact a protective collar ($515 calls / $467 puts, ~60 days, 1.5% notional premium ceiling) on the decision date to lock in the repeatedly validated lesson that deferred hedging destroys alpha; tighten stop to $467 (closing basis, ~2.4 ATR below entry) below the 200 SMA to confirm genuine breakdown intent; and narrow the trim condition to only stalled rallies with volume drying AND MACD failing to cross zero, correcting the conservative analyst's overcorrection that would trim exactly the position to hold through confirmed breakouts.

Outcome

✓

Return

-0.58%

Status

scored

The decision maintains LIN at current size with three execution refinements: transacting a protective collar ($515 calls / $467 puts, ~60 days, premium ceiling 1.5% notional) on the decision date to address the dominant alpha-killer of deferred hedging, tightening the stop to $467 based on ATR ($9.67), and implementing a three-tier add framework. The rating is Hold with unanimous consensus across all three analysts, as the $487-490 level lacks margin of safety given 31.6x trailing/25x forward P/E and 2.08 PEG, but fundamental franchise quality (record $8.1B backlog, 28% margins, 31-year dividend growth) precludes trimming.

Outcome

✓

Return

+0.50%

Status

scored

LIN warrants a HOLD at $487.57 as the 200 SMA regime remains intact while three failed reclaims at $491–$495 confirm unresolved overhead supply; the forward P/E of 24.9x versus 18.5% historical EPS CAGR lacks margin of safety. Execute a protective collar ($515 calls/$467 puts, ~60 days, ≤1.5% premium) on the decision date, maintain the $462 closing stop, and follow a three-tier add framework: starter adds at 25% size on >$489 with RSI>50 and MACD expansion, standard adds at 50% on >$508 breakout with volume >3M, and value adds at 200 SMA zone ($465–$472); do not add above $495 without confirmation.

Outcome

✓

Return

+1.30%

Status

scored

The unanimous Hold rating on LIN at $481 reflects zero margin of safety at 24.6x forward P/E with broken technicals (price 5.3% below 50 SMA at $508), though the 200 SMA at $474.99 has held twice as a structural floor backed by fortress fundamentals and $4B annual buybacks. Three execution refinements are mandated: transact a protective collar ($515 calls / $470 puts, ~60 days, premium ceiling 1.5% notional) on the decision date, tighten the stop to $466-467 (July 31 capitulation low), and remove the trim-toward-$505 recommendation. The Overweight trigger requires confirmed close above $508 on volume exceeding 3M with RSI above 45 within 5 trading days of 200 SMA defense.

Outcome

✓

Return

+0.03%

Status

scored

Maintain LIN at Hold with three key execution refinements: transact a protective put or collar at $465-470 strike on the decision date rather than deferring; remove the trim-toward-$505 recommendation that crystallizes losses into overhead supply at the 50 SMA breakdown zone; and add a partial-starter trigger (25-30% of normal size) on confirmed 200 SMA retest with bullish reversal candle as a middle path. The unanimous Hold reflects no margin of safety at 31x TTM/24.6x forward P/E in a technically broken, catalyst-desert environment, balanced against structural defense at the 200 SMA ($474.65) with $4B annual buybacks and 85% contracted revenue.

Outcome

✓

Return

+0.51%

Status

scored

Maintain LIN at Hold with the protective collar ($515 calls / $467-470 puts) transacted as active risk management on the decision date rather than deferred guidance. Position sizing is modestly below benchmark weight, with the $467 stop placed below the 200 SMA ($474.37) to confirm breakdown intent while respecting the $10.13 ATR. The add trigger requires confirming close >$485 with volume >3M AND RSI >45 AND MACD histogram contracting within 5 trading days, while trim triggers at $465 (25-33% reduction) and $460 (full exit).

Outcome

✓

Return

+0.92%

Status

scored

LIN maintains HOLD at $474.12 near its 200 SMA with a $504 price target over 2-4 weeks (binary resolution) and 3-6 months tactically. The protective collar ($510 calls / $440 puts) must be transacted as active risk management on the decision date rather than deferred as optional guidance—the prior 6 consecutive Hold calls produced deteriorating alpha outcomes precisely because hedges were left as guidance instead of being executed.

Outcome

✗

Return

-1.74%

Status

scored

Maintain LIN at Hold with three specific refinements: tighten stop from $455 to $465, execute protective puts at $465 strike as mandatory hedging rather than optional guidance, and require ONE strong confirmation signal (not two) for tactical position adds in the $470-478 zone. The fundamental engine remains intact (record $8.1B backlog, 26% EPS growth), but the 24.7x forward P/E with 2.09 PEG ratio and broken chart pattern create asymmetric risk that favors disciplined patience over aggressive accumulation or defensive exit.

Outcome

✓

Return

+0.95%

Status

scored

Maintain LIN core exposure while executing a 10-15% trim at $478 to lock in cushion from the post-earnings drawdown, with the stop moved to $468 to absorb the $10.54 ATR. Actively transact the protective collar ($515 calls / $470 puts) as the primary risk management tool rather than optional guidance, with hard invalidation at decisive close below $473.73 on volume >3M and re-engagement trigger requiring close >$485 with volume >3M AND RSI >40 within 5 trading days of 200 SMA defense.

Outcome

✓

Return

-0.26%

Status

scored

Maintain LIN exposure at current weight with a protective collar (sell $515 calls, buy $470 puts) rather than leaving hedging optional; add 10-15% only on confirmed $473 support hold meeting all four technical conditions (two daily closes above, reversal candle, RSI > 40, MACD histogram contraction), and trim 20-30% on decisive break below $473 with expanding MACD and RSI < 30. The 8/11 lesson that the prior collar should have been transacted—not left as guidance—directly informs this decision to execute the hedge immediately given the deteriorating alpha pattern across three consecutive Hold calls and the binary $473 test expected within 2-4 weeks.

Outcome

✗

Return

-2.26%

Status

scored

Maintain existing LIN exposure with no new adds at $490, as the $8.1B backlog and margin expansion thesis is valid but timing is wrong given the 31.6x trailing P/E already pricing in quality without transformation catalyst. Wait for either a successful 200 SMA test ($472.90) with bullish reversal on volume greater than 3M shares, or a 50 SMA reclaim above $511; a close below $465 shifts to Underweight. The $504 price target implies 3% upside with bounded 8-12% downside risk to $431-450 on multiple compression, supporting a tactical Hold across the 3-6 month horizon.

Outcome

✓

Return

-0.39%

Status

scored

Maintain existing LIN position with a calibrated 10-15% tactical add at $492 given ATR-based structural stop at $466.88, honoring the prior Hold verdict's structural thesis (oligopoly, 900bps margin expansion, $8.1B backlog) while addressing the ABT/prior-LIN lesson that waiting for lagging-indicator triggers risks forfeiting the base case in quality compounders.

Outcome

✓

Return

+0.51%

Status

scored

Maintain LIN at Hold given the record $8.1B backlog and 11.3% EPS growth providing fundamental support, but damaged momentum (MACD at -8.05, descending 50 SMA) and a stretched 31.6x P/E with 2.09x PEG argue against aggressive adding into weakness. Adopt a tactical re-engagement framework with 10-15% adds on a single confirmation signal (successful $478 retest on declining volume), structural stop at $472.91 weekly close, with trim targets at $504-508 on stall signals.